Thierry Berney, Switzerland
State of the art of islet transplantation for treatment of type 1 diabetes as an example of allogeneic therapeutic cell replacement therapy

Dr. Giacomo Lanzoni, United States
Novel strategies in cell therapies for diabetes, beyond conventional immunosuppression

Dr. Alessandro Grattoni, United States
Preclinical evaluation of niche devices for localized immunomodulation in islet transplantation in patients with type 1 diabetes and applicability of the device in other regenerative medicine fields

Dr. Shane T Grey, Australia
Engineering islets for tolerance: a first in human safety study

Prof. Kenneth Brayman, United States
Panel discussion